Yoshiki Murakami

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. doi request reprint Regulation of the hepatitis C virus genome replication by miR-199a
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University, Shogoin Kawaharacho, Kyoto, Japan
    J Hepatol 50:453-60. 2009
  2. pmc Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C
    Koji Onomoto
    Institute for Viral Research and Graduate School of Bioscience, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e19799. 2011
  3. pmc Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University Graduate School of Medicine, 53 Shogoinkawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    BMC Med Genomics 3:48. 2010
  4. pmc The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    PLoS ONE 6:e16081. 2011
  5. doi request reprint Impact of Hepatitis B Virus Integration Into Liver Tissue on the Efficacy of Peginterferon and Ribavirin Therapy in Hepatitis B Virus-negative Chronic Hepatitis C Patients
    Hidenori Toyoda
    Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Clin Gastroenterol 48:73-9. 2014

Collaborators

Detail Information

Publications5

  1. doi request reprint Regulation of the hepatitis C virus genome replication by miR-199a
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University, Shogoin Kawaharacho, Kyoto, Japan
    J Hepatol 50:453-60. 2009
    ..microRNAs (miRNAs) are non-coding RNAs that regulate gene expression, and they have recently been shown to play an important role in viral replication...
  2. pmc Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C
    Koji Onomoto
    Institute for Viral Research and Graduate School of Bioscience, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e19799. 2011
    ..Although the antiviral mechanism of genetically altered IL28B is unknown, IL28B polymorphism is considered a good predictor of IFN combination treatment outcome...
  3. pmc Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University Graduate School of Medicine, 53 Shogoinkawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    BMC Med Genomics 3:48. 2010
    ..In this study we administered the standard combination treatment to CHC patients. We then examined their miRNA expression profiles in order to identify the miRNAs that were associated with each patient's drug response...
  4. pmc The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families
    Yoshiki Murakami
    Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    PLoS ONE 6:e16081. 2011
    ..In order to clarify how the aberrant expression of miRNAs participates in development of the liver fibrosis, we analyzed the liver fibrosis in mouse liver fibrosis model and human clinical samples...
  5. doi request reprint Impact of Hepatitis B Virus Integration Into Liver Tissue on the Efficacy of Peginterferon and Ribavirin Therapy in Hepatitis B Virus-negative Chronic Hepatitis C Patients
    Hidenori Toyoda
    Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Clin Gastroenterol 48:73-9. 2014
    ..We investigated the prevalence of HBV integration and its association with the outcome of peginterferon (PEG-IFN) and ribavirin combination therapy in HBsAg-negative chronic hepatitis C patients...